Acertis Pharms Company Profile
What is the competitive landscape for ACERTIS PHARMS
ACERTIS PHARMS has six approved drugs.
Summary for Acertis Pharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for Acertis Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acertis Pharms | LEVORPHANOL TARTRATE | levorphanol tartrate | TABLET;ORAL | 211484-001 | Dec 13, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acertis Pharms | PROMETRIUM | progesterone | CAPSULE;ORAL | 019781-002 | Oct 15, 1999 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acertis Pharms | METOLAZONE | metolazone | TABLET;ORAL | 218606-002 | Apr 17, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
